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Summary
Osteoporosis is a major public health problem affects
many millions of people around the world. It is a metabolic
bone disease characterized by loss of bone mass and
strength, resulting in increased risk of fractures. Several
lifestyle factors are considered to be important determi-
nants of it and nutrition can potentially have a positive im-
pact on bone health, in the development and maintenance
of bone mass and in the prevention of osteoporosis. There
are potentially numerous nutrients and dietary compo-
nents that can influence bone health, and these range
from the macronutrients to micronutrients. In the last
decade, epidemiological studies and clinical trials showed
micronutrients can potentially have a positive impact on
bone health, preventing bone loss and fractures, decreas-
ing bone resorption and increasing bone formation. Con-
sequently, optimizing micronutrients intake might repre-
sent an effective and low-cost preventive measure against
osteoporosis.
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Introduction
Osteoporosis is a major public health problem affects many mil-
lions of people around the world (1). It is characterized by low bone
mass and microarchitectural deterioration of bone tissue, leading
to enhanced bone fragility and consequent increase in fracture risk
(2). More than 200 million people are presumably affected
worldwide; annually there are 3.5 million new fragility fractures and
this incidence will increase in the next years (3). Osteoporotic frac-
tures are a major cause of morbidity and disability in the elderly
and can lead to premature death. In addition, they impose a con-
siderable economic burden on health services, costing many bil-
lions of dollars each year (4). Osteoporosis is a multifactorial di-
sease and several factors, unmodifiable, such as genetic, sex, age,
and modifiable such as lifestyle are considered to be important
determinants of it (5). Nutrition is an important modifiable factor
in the development and maintenance of bone mass and in the pre-
vention of osteoporosis. Physiologically, bone is an active tissue
constantly remodeled by concerted and coordinated interactions
between osteoclasts, involved in bone resorption, and osteobla-
sts, which ensure bone formation and mineralization; for this con-
tinuous remodeling, an adequate supply of macronutrients and mi-
cronutrients substrate, such as vitamins and minerals, are nee-
ded to support bone remodeling. In recent years, there has been
a growing interest in studies concerning the role of dietary mi-
cronutrients on bone health (6). Many of the micronutrients con-
sumed as part of a Westernized diet can potentially have a po-
sitive impact on bone health. In the last decade major attention
was focused on the role of calcium in nutritional prevention of osteo-
porosis, furthermore, several additional dietary inorganic minerals,
also defined micronutrients, are known to be important for ske-
leton recently, and their intake is positively associated with bone
mass (7, 8). Micronutrients play a prominent role in bone health:
several minerals have direct roles in hydroxyapatite crystal formation
and structure, other nutrients have indirect roles as cofactors or
as regulators of cellular activity (9).
Calcium
Calcium is one of the main bone-forming minerals and 99% of the
body’s calcium resides in the skeleton. Calcium intake is one of
the important modifiable environmental factors for the normal de-
velopment of skeleton in young and the maintenance of bone mass
in adult (10). Higher calcium intake has been related to higher bone
mass in adults and post-menopausal women and this effect has
been examined in a large number of randomized controlled trials
(11-14). These trials have shown that in older people with a ba-
seline calcium intake of 500-1000 mg/day, increasing the intake
by a further 500-1200 mg/day can prevent bone loss. Studies in
men showed similar effects (15). In the last decade, meta-analy-
sis have concluded that calcium intake is a significant determinant
of BMD but the magnitude of the effect is small, at about 1% of
the population variance (16, 17). Recently, a meta-analyses con-
firms that increasing calcium intake from dietary sources slightly
increased bone mineral density by 0.6-1.8% over one to two years
at all sites, except for the forearm (18). 
The influence of calcium supplementation on fracture risk is still
a matter of debate, having reported in literature contrasting re-
sults. In fact, low calcium intake correlates with increased risk of
hip fracture, but increasing intake above 750 mg/day does not
correlate with progressively lower risks of hip fracture (19, 20).
A recent meta-analysis indicates that dietary calcium intake is not
associated with risk of fracture, and there is no evidence currently
that increasing dietary calcium intake prevents fractures (21). The
recommended dietary allowance of calcium ranges from 1000 to
1.300 mg/day.
Microelements for bone boost: 
the last but not the least
Mini-review
_CCMBM 3_2016.qxp_-  23/01/17  09:39  Pagina 181
Magnesium
Magnesium, an ubiquitous element in various organ systems and co-
factor of hundreds of enzymes, is increasingly recognized as an im-
portant contributor to bone health.  About 60% of all magnesium in
the body is found in bone, where it is a structural constituent, along
with calcium and phosphate; this magnesium makes up about 1%
of the total bone mineral content (22). In several studies on animals,
dietary magnesium restriction promotes osteoporosis, fragility, mi-
crofractures of the trabeculae and reduction of bone’s mechanical pro-
perties (23); conversely, in ovariectomized rats magnesium supple-
mentation increased osteocalcin, reduced parathyroid hormone and
deoxypyridinoline, and increased bone strength and fracture resistance
(24). Also in humans magnesium deficiency contributes to osteoporosis;
in Framingham study magnesium intake was positively associated
with bone mass density (25). Recently, the protective effect of high
magnesium intake on bone quality was documented in healthy wo-
men using ultrasound measurement in calcaneus (26) and a trial shows
a positive effect of magnesium supplementation on the accrual of bone
mass in the hip of young women (27). Several direct and indirect me-
chanisms contribute to the effects of low magnesium on bone den-
sity: low magnesium can directly affect the bone by altering the struc-
ture of apatite crystals; magnesium deficiency is also associated with
reduction of PTH and 1,25(OH2) D levels and low grade inflamma-
tion and endothelial dysfunction, with a well-known relation between
inflammation and bone loss (28). Dietary sources of magnesium in-
clude almonds, cashews and peanuts, raisin bran cereal, potato skins,
brown rice, kidney beans, black-eyed peas and lentils. A modest sup-
plementation with 250 mg/day of magnesium is reasonable to sup-
port bone health, and for other aspects of general health (29).
Zinc
Zinc is a cofactor in many metalloenzymes and is an extremely
important element from the point of view of bone health; skele-
ton contains a large proportion of the total body burden of zinc (30).
In experimental animal models, zinc defi ciency has been asso-
ciated with altered osteoblastic activity and decreased synthesis
of collagen, chondroitin sulfate, and alkaline phosphatase (7); it
is also observed that zinc inhibited loss of bone mass in ova-
riectomized rats and similar beneficial effects of zinc in rats with
low calcium intake (31, 32). The importance of zinc in bone me-
tabolism has been recognized in humans. A study showed the
mean concentrations of serum zinc were significantly lower in osteo-
porotic women than in either osteopenic or normal women (33).
One study showed that serum zinc level in patients with bone frac-
tures was significantly lower than normal range and supplemen-
tation with zinc had positive effect on callus formation (34). A re-
cent study showed that the mean dietary intake of magnesium,
zinc and calcium in post-menopausal women with low bone den-
sity were significantly lower than recommended dietary allowan-
ce (35). Zinc plays a pivotal role in the regulation of bone ho-
meostasis. Many zinc-related proteins are found to involve in the
regulation of cellular function in osteoblasts and osteoclasts. Zinc
stimulates cell differentiation, cell proliferation, and mineralization
in osteoblasts through gene expression of various proteins including
type I collagen, alkaline phosphatase, and osteocalcin (36). Further-
more, zinc inhibits osteoclastic bone resorption suppressing osteo-
clast-like cell formation, inhibits action of RANKL in pre-osteoclasts
and stimulates gene expression of OPG in osteoblastic cells (36).
Zinc is found in a wide variety of foods including red meat, lamb,
shell fish, seeds, nuts, dairy products, poultry and beans. The re-
commended daily minimum intake of zinc is 12 mg and for bone
health 15 mg is recommended (37).
Manganese
Manganese is distributed in tissues throughout the body, inclu-
ding bone; manganese activates phosphatases, kinases, de-
carboxylases and glycosyltransferases, also is a constituent of
some enzymes (38). In recent decades research has uncovered
the special role manganese plays as a co‐factor in the formation
of bone cartilage and bone collagen, as well as in bone mine-
ralization (39). Multiple studies in rats have shown diets lower in
manganese prevent cartilage formation and produce osteopenia,
as result of an imbalance between osteoblastic and osteoclastic
activity (40). In humans it has been reported that osteoporotic
subjects have low serum manganese level (41), furthermore, in
a randomized, controlled, two-year trial, a supplement containing
manganese, copper and zinc in combination with a calcium sup-
plement was found to be more effective than the calcium sup-
plement alone in preventing spinal bone loss (42). The skeleton
abnormalities could be due to a reduction in proteoglycan
synthesis secondary to a reduction of manganese dependent gly-
cosyltranserases; recently, in manganese deficient rats it has been
reported an alteration in synthesis of IGF-1, involved in regular
bone formation (43). Dietary sources of manganese include ce-
reals, nuts, pineapples, beans, mollusks, dark chocolate, cin-
namon, and tea. The Recommended Daily Allowance of man-
ganese is 1.8 mg/day for women and 2.3 mg/day for men; rela-
tive to bone health, adequate intake of manganese has not been
established. 
Boron
The trace mineral boron is a micronutrient with diverse and vi-
tally important roles in metabolism. Recent data from animal and
human studies suggest boron may be important for mineral me-
tabolism and prevention of osteoporosis (44). There is eviden-
ce that compositional and functional properties of bone, as well
as mineral status required for bone health, are affected by bo-
ron status with a worsening under circumstances of boron de-
privation (45-47). In animals, supplemental boron as boric acid
has been shown to increase bone strength (48-50) and two stu-
dies published recently (51, 52) found that healing of the alveo-
lar bone, a ridge of compact bone that contains the tooth sockets
on the maxillae and mandible, was inhibited in boron deficient rats.
In two human studies, boron deprivation was associated with de-
creased plasma calcium and calcitonin and increased urinary cal-
cium excretion (45, 46). The mechanism by which boron acts on
bone has not yet been established; it has been shown to enhan-
ce collagenase and cathepsin D activity in fibroblasts that mo-
dulate the turnover of extracellular matrix, allowing for changes
in composition, structure, and strength of bones (53). Beneficial
effects on bone metabolism can due in part to the roles it plays
in both producing E2 and in increasing its biological half-life and
that of vitamin D (54). The Recommended Daily Allowance of bo-
ron has not been established; however, a study of postmenopausal
women reported that 3-4 mg/die of boron for a period of one year
improved bone mineral density (55), thus, it is reasonable sup-
plement diet by consumption of foods rich in boron such as pru-
nes, raisins, dried apricots, or avocados.
Copper
Copper is an essential trace mineral that has only recently been
found to play an important role in bone health maintenance. Stu-
dies in animals showed rats fed a copper deficient diet had re-
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duced bone mineral content and reduced bone strength (56). In
humans severe copper deficiency is known to cause skeletal ab-
normalities, for example, osteoporosis is associated with ma-
labsorption of copper in Menkes’ disease (57). Elderly patients
with fractures of the femoral neck were found to have significantly
lower serum copper levels than age and sex matched controls
(58). Post-menopausal women with a high dietary calcium intake
combined with a high serum copper level had a greater lumbar
bone density than women with low calcium intake and low serum
copper (59). In a 2-year double-blind, placebo controlled study,
bone loss in post-menopausal women given combined calcium
and copper, manganese and zinc supplements was significan-
tly less than in the placebo group and in groups taking the tra-
ce mineral or calcium alone (60). The role of copper in bone for-
mation, skeletal mineralization and integrity of the connective tis-
sue is still not fully understood. As a general enzymatic cofac-
tor, it actives lysil oxidase which induces the formation of lysine
crosslinks in collagen and elastin (61), removes bone free radi-
cals as a cofactor of antioxidant enzymes (62), directly inhibits
osteoclastic resorption (63). Dietary copper is available in a wide
variety of foods including meats, seafood, nuts and grains. The
recommended daily intake of copper adequate for bone health
in adults is 0.9 mg/day (64).
Silicon
Silicon, the most abundant mineral on earth, appears to have a
beneficial role in bone health and formation (65). Severe dietary
silicon deprivation in growing animals appears to cause abnormal
growth and defects of the connective tissues (66, 67). In recent
studies, supplementation with silicon in ovariectomised rats reduced
bone resorption and bone loss and increased bone formation and
bone mineral content (68, 69). In humans, two epidemiological stu-
dies have reported that increase silicon intake correlated with in-
creased bone mineral density for men, premenopausal women,
and postmenopausal women on hormone replacement therapy
(70, 71). Other studies showed in osteoporotic subjects silicon sup-
plementation resulted in increased bone volume (72) and increases
in femoral and lumbar spine BMD (73). A recent study on osteo-
penic and osteoporotic subjects, shows silicon supplementation
induced a trend for increased bone formation markers in serum
and a slight significant increase in femoral BMD (74). Mechani-
sms of health silicon effect on bone are not clear but it has been
suggested silicon involvement in the radical-dependent prolyl-hy-
droxylase pathway (75) during type I collagen formation. Others
have suggested a structural role in the cross-linking and stabili-
zation of collagen and glycoaminoglycans (76); furthermore
orthosilicic acid stimulates human osteoblasts and osteoblast-like
cells to secrete type I collagen and other markers involved in bone
cell maturation and bone formation (77). Dietary sources of sili-
con include whole grains and cereals, carrots and green beans.
Recent epidemiological findings suggest that intakes near 25 mg/d
might promote bone health (78).
Iron
Iron is essential in oxygen transport and participates in many enzy-
matic systems in the body, with important roles in collagen synthe-
sis and vitamin D metabolism. Iron-deficient rats have been shown
to have poorly mineralized skeletons and pathological changes
in the microarchitecture of trabecular bone (79). In healthy po-
pulations the relationship between iron status and bone metabolism
is controversial. Results show positive correlation between serum
ferritin and BMD in elderly men but not in women (80). In contrast,
there was a negative correlation in women older than 45 years of
age (81), and no association between BMD and either transfer-
rin saturation or ferritin in men (82). Buyukbese et al. (83) did not
observe differences in ferritin levels between osteoporotic post-
menopausal women and controls. Different mechanisms by whi-
ch iron deficiency affects bone have been suggested. On the one
hand, there is the role of iron as an essential cofactor for hy-
droxylation of prolyl and lysil residues of procollagen. On the other
hand, there is its participation in vitamin D metabolism through the
cytochromes P450. Furthermore, hypoxia related to anemia is a
major stimulator of bone resorption, inducing osteoclastogenesis
(84). Relative to bone mineral density, adequate intake of iron has
not been established.
Selenium
Selenium is an essential nutrient and plays critical roles in a va-
riety of physiological processes as constituent of selenoproteins
which function as antioxidative scavengers and it has been reported
that selenium inadequacy can influence bone metabolism (85).
In animal studies, deprivation of this micronutrient increased bone
resorption and changed bone microarchitecture with a reduction
in BMD and bone volume (86, 87). Similarly, studies in humans
founded that selenium status was inversely related to bone re-
modeling and positively correlated with BMD in post-menopau-
sal women (88). A case-control study found selenium intake to be
inversely associated with reduced risk of osteoporotic hip fracture
(89). These effects can be explained by inhibiting oxidative stress,
in fact, adequate selenium intake appears to play an essential role
in osteoclast/osteoblast cell proliferation and differentiation
enhancing osteoblastic differentiation by the reduction of free ra-
dicals (90).
The main sources of selenium for nutrition are wheat, red meat
and sea food with a recommended daily allowance of 55 μg/day
(91).
Conclusion
Osteoporosis is a multifactorial disease and nutrition is an important
modifiable factor in the development and maintenance of bone
mass and in the prevention of osteoporosis. There are potentially
numerous nutrients and dietary components that can influence bone
health, and these range from the macronutrients to micronutrients.
With regard to bone health, there has been a growing interest not
only in the traditional nutrient related to bone as calcium and vi-
tamin D but also in micronutrients. Epidemiological studies and
clinical trials showed micronutrients can potentially have a posi-
tive impact on bone health, preventing bone loss and fractures,
decreasing bone resorption and increasing bone formation. The
micronutrient needs for optimizing bone health can be easily met
by a healthy diet that is high in fruits, vegetables and sea food with
a modest intake of meat. Consequently, optimizing micronutrients
intake might represent an effective and low-cost preventive mea-
sure against osteoporosis.
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